(R)-1-(6-(Trifluoromethyl)pyridin-3-yl)ethanamine oxalate

Catalog No. :
ACKLRF393
CAS No. :
1956437-86-7
Molecular Formula :
C10H11F3N2O4
Molecular Weight :
280.20

IUPAC Name:(R)-1-(6-(trifluoromethyl)pyridin-3-yl)ethan-1-amine oxalate

(R)-1-(6-(Trifluoromethyl)pyridin-3-yl)ethanamine oxalate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$1135.00Login to see priceInquiryInquiry
1g97%$1893.00Login to see priceInquiryInquiry
5g97%$4829.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-1-(6-(Trifluoromethyl)pyridin-3-yl)ethanamine oxalate
IUPAC Name(R)-1-(6-(trifluoromethyl)pyridin-3-yl)ethan-1-amine oxalate
Molecular FormulaC10H11F3N2O4
Molecular Weight280.20
SMILESC[C@@H](N)C1=CC=C(C(F)(F)F)N=C1.O=C(O)C(O)=O
InChI KeyJIRAJJMQWIVBJP-NUBCRITNSA-N
Synonym3-Pyridinemethanamine, α-methyl-6-(trifluoromethyl)-, ethanedioate (1:1), (αR)-;(R)-1-(6-(trifluoromethyl)pyridin-3-yl)ethan-1-amine oxalate
CAS No.1956437-86-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACKLRF393 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACDTQJ324 route compound structure diagram
    ACDTQJ3247447-41-8 In Stock
  6. Then
  7. ACKLRF393 route product structure diagram
    ACKLRF3931956437-86-7
Inquiry

2. ACKLRF393 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKLRF393 route product structure diagram
    ACKLRF3931956437-86-7
Inquiry

Comments (0)